The Preprint Is In!

Results from the 2025 personalized precision medicine trial showed significant improvement in cognitive function.

The Protocol outperformed all other available treatments for cognitive decline. In addition to improved cognition, participants showed significant improvements in health, including lower blood pressure, healthier body composition, improved insulin sensitivity, better hemoglobin A1c levels, more favorable lipid profiles, and enhanced methylation status.

Download and read the preprint below.